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SUMMARY 
 
The United States Environmental Protection Agency (USEPA) requested that the Agency for 
Toxic Substances and Disease Registry (ATSDR) evaluate soil samples collected in 2017 and 2018 
at residential properties on the USEPA Arsenic Mine Site in Kent, Putnam County, New York. 
The USEPA collected samples to determine the extent of arsenic in residential soils and whether 
prompt action is needed to reduce harmful exposures to arsenic-contaminated soils and mine 
tailings. The New York State Department of Health (NYSDOH) reviewed the soil data collected 
by the USEPA and evaluated the public health implications of the contamination. This health 
consultation formalizes the NYSDOH’s evaluation of the data, and this health consultation was 
prepared under a cooperative agreement with ATSDR. 
 
The intent of this health consultation is to ensure that residents have the best information 
possible about how environmental contaminants might affect their health. A health 
consultation provides advice on specific public health effects that could occur following human 
exposure to a hazardous material. The evaluation of arsenic contaminated soil at select 
residential properties forms the basis for the conclusions and recommendations in this health 
consultation. The evaluation does not consider other possible sources of arsenic exposure such 
as inhalation of arsenic contaminated soil or dust, consumption of untreated drinking water, 
consumption of home raised animal products, or consumption of fruits and vegetables grown in 
contaminated soil. Consideration of these additional potential exposure pathways may likely 
support and strengthen the conclusions and recommendations contained in this health 
consultation. 
 
CONCLUSION 1 
 
The NYSDOH and ATSDR conclude that short-term ingestion exposure of children to arsenic in 
shallow (zero to six inches) soils with the highest arsenic levels at residential properties on the 
Arsenic Mine Site pose an immediate and significant threat to human health, thus constituting 
an urgent public health hazard. 
 
BASIS FOR CONCLUSION 
 
Short-term exposure to arsenic in residential soil could result in adverse health effects. For all 
ten residential properties evaluated, a single ingestion of a large amount of soil (i.e., 5 grams) 
containing the maximum arsenic soil level found at each property, by a 1 to 2-year-old child 
exhibiting pica1 behavior, results in an arsenic dose that either exceeds or approaches the 
short-term arsenic exposure level that causes non-cancer health effects. On seven properties, a 
single ingestion of a smaller amount of soil (i.e., 200 milligrams) containing the maximum 
arsenic level results in an arsenic dose that either exceeds or approaches the short-term arsenic 
exposure level that causes non-cancer health effects. Health effects that can result from short-
                                                     
1 Pica is defined by behavior that involves eating and ingesting non-food substances, such as soil.  
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term, high-level arsenic exposure include vomiting, headaches, stomach cramps, diarrhea, and 
facial swelling, especially around the eyes.  These effects are typically temporary and should 
subside when exposure to arsenic ceases. 
 
CONCLUSION 2 
 
The NYSDOH and ATSDR conclude that long-term ingestion and dermal exposure of children 
and adults to arsenic in shallow soil at residential properties on the Arsenic Mine Site pose a 
significant threat to human health and constitute a public health hazard. 
 
BASIS FOR CONCLUSION 
 
Long-term exposure to arsenic in residential soil could result in adverse health effects. For all 
ten residential properties evaluated, long-term arsenic exposure in soil results in an estimated 
lifetime cancer risk of over 1 in 10,000.  For six of the residential properties, the arsenic 
exposure results in an estimated lifetime cancer risk of 1 in 1,000 or higher and for three 
properties, the estimated cancer risk is over 1 in 100, which is unusually high for environmental 
exposures. Long term exposure to high levels of arsenic is known to cause cancer of the skin, 
lung, and bladder in humans. Regarding non-cancer health risks, long-term exposure to arsenic 
in soil at all properties results in an arsenic dose that either exceeds or approaches the long-
term arsenic exposure level that causes health effects. Long-term human exposure to arsenic 
also causes skin hyperpigmentation and keratosis, or a darkening and thickening of the skin on 
the hands and feet, as well as other adverse health effects [USEPA 1991; ATSDR 2007]. 
 
RECOMMENDATIONS 
 
Based on the significantly increased risk for adverse health effects, the NYSDOH and ATSDR 
strongly recommend that the USEPA implement immediate actions to prevent or reduce the 
potential for residents, especially children, to be exposed to arsenic contamination in 
residential soils. 
 
Until a long-term remedial action can be put in place, the NYSDOH and ATSDR recommend 
residents implement the following interim measures to reduce arsenic exposure: 
 
 People, especially children, should minimize direct and repeated contact with bare soils.  
 Maintain a grass or mulch cover wherever possible to help prevent direct contact with 
the soil. 
 Wipe shoes on doormat or remove shoes before entering the home. Apply general good 
housekeeping practices by periodically damp mopping floors, vacuuming (using a HEPA 
filter if available), and cleaning furniture to help reduce exposure to outdoor soil that 
might be tracked indoors. Avoid the use of brooms. 
 Avoid unnecessary digging in the dirt. 
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 Children and adults should wash hands after outdoor activities to help reduce the 
potential for exposure. 
 Wash children’s toys regularly. 
 Refrain from landscaping activities that increase exposure to soil and create bare areas of 
soil.  
 Refrain from eating food or smoking when working in the yard. 
 Refrain from eating home raised fruits, vegetables, and animal products. If residents 
choose to garden, they should grow crops in raised bed gardens and containers with 
clean soil imported from a non-contaminated area or bagged soil bought commercially 
instead of the existing soil. Residents should wear gloves when gardening and dispose or 
wash gloves thoroughly after each use. 
 Regularly wash pets that may go outdoors and contact the soil. 
 Properly maintain water treatment systems in accordance with the manufacturer’s 
specification. 
 
People who have further questions about how to reduce their exposure to arsenic should 
contact the NYSDOH. The NYSDOH and ATSDR also recommend that residents who are 
concerned about possible exposure to, and effects from, arsenic contaminated soil should 
discuss these concerns with their health care provider. 
 
NEXT STEPS 
 
The NYSDOH and ATSDR will continue to coordinate with the USEPA, New York State 
Department of Environmental Conservation (NYSDEC), and the Putnam County Health 
Department, to implement the recommendations contained in this health consultation. 
 
The NYSDOH and ATSDR will review information as it becomes available, evaluate the public 
health implications of any additional sampling results, and recommend public health actions as 
needed. 
 
The NYSDOH will coordinate with the ATSDR, NYSDEC, Putnam County Health Department, 
USEPA, and the Town of Kent to provide health education to residents whose properties are 
affected by arsenic contamination. Activities may include public meetings, public availability 
sessions, preparation of factsheets, and information sessions and mailings for local physicians 
to assist them in responding to their patients’ concerns. 
 
The NYSDOH will continue, as needed, to provide support to community members about this 
health consultation or other health concerns that may arise. This report will be placed in the 
local repository and provided to people who request it. 
 
  
 4 
 
FOR MORE INFORMATION 
 
If you have questions about this health consultation or other health concerns that may arise, 
please contact the NYSDOH at 518-402-7860. 
 
A copy of this health consultation will be available on the NYSDOH public website at: 
https://www.health.ny.gov/environmental/ 
and the ATSDR public website at:  
https://www.atsdr.cdc.gov/HAC/PHA/HCPHA.asp?State=NY. 
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BACKGROUND 
Statement of Issue 
 
The United States Environmental Protection Agency (USEPA) requested that the Agency for 
Toxic Substances and Disease Registry (ATSDR) evaluate soil samples collected at residential 
properties on the USEPA Arsenic Mine Site [site] in Kent, Putnam County, New York. The USEPA 
collected the samples to determine the extent of arsenic in residential soils and whether 
prompt action is needed to reduce harmful exposures to arsenic-contaminated soils and mine 
tailings. The New York State Department of Health (NYSDOH) reviewed the soil data collected 
by the USEPA and evaluated the public health implications of the contamination. This health 
consultation formalizes the NYSDOH’s evaluation of the data. The NYSDOH prepared this health 
consultation under a cooperative agreement with ATSDR. 
 
Site Description and History 
 
The former Arsenic Mine is in the Town of Kent, in Putnam County, New York, near the 
intersection of Gipsy Trail Road and Mt. Nimham Court (Appendix A, Figure A1). Former mine 
entrances and tailings piles (residual materials separated out during mining activities) exist on 
nearby residential properties and the Nimham Mountain Multiple Use Area (MUA). There are 
two main mine entrances, or shafts. The shaft at the northern end of the mine, referred to as 
the northern entrance, is located on a private residential property. The shaft to the south, 
referred to as the southern entrance, is located within the Nimham Mountain MUA. The former 
mine entrances are now flooded or filled in, preventing casual entry.  
 
The area is sparsely populated, and the terrain is highly variable, with steep, forested hillsides. 
Occupied properties in the area generally consist of single-family residential homes. Public 
water is not available in the area; residents rely on private wells for their drinking water. 
 
Mining began in the area around the mid-1800s and was continued by various companies until 
1918. Rocks were crushed on site to concentrate the ore. Ultimately, the ore was used to 
manufacture shot, flint, glass, pharmaceuticals, poisons, and chemicals [Weston Solutions, Inc. 
2017, 2018a, 2018b]. Mining operations ceased by 1918 due to the lack of a satisfactory 
smelting forge nearby for processing the ore. Some of the ten residential homes were 
constructed in the area that was used for mining operations.  
 
In the 1950s, a property owner regraded the area around the northern mine entrance to create 
a small ski slope. Some remnants of electrical lines that powered a small ski lift are still visible. 
In December 1987, residents at a single property living adjacent to the northern mine shaft 
were hospitalized with arsenic poisoning from their drinking water well [NYSDOH 1987]. 
Putnam County Department of Health sampling determined that the residential drinking water 
well was contaminated with arsenic much above state and federal drinking water standards. 
Soil samples collected on the residential property confirmed that the home was built upon 
mine tailings/mine wastes. Due to arsenic poisoning, three residents in the home required 
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chelation therapy. In consultation with New York State Departments of Environmental 
Conservation and Health, the USEPA requested that ATSDR evaluate the health risk associated 
with arsenic contaminated drinking water for residents. ATSDR recommended the residents of 
this property be put on a permanent acceptable water supply totally disconnected from any 
source of arsenic [ATSDR 1988]. At that time, the USEPA installed an alternate drinking water 
system at the property, and both USEPA and Putman County Health Department provided 
health education information to the family living at the property. Two additional private 
drinking water wells and one public supply well sampled by the Putnam County Health 
Department in 1987 were found to contain arsenic at concentrations approaching or slightly 
above the state and federal drinking water standards. A limited drinking water sampling event 
was conducted by the USEPA, and the Putnam County Health Department performed routine 
sampling through 1992. Installation of filter systems on the drinking water wells proved to be 
effective in removing arsenic. 
 
The 1987 sampling event identified a need for additional information about the potential for 
arsenic exposures in the area. In the late 1980s and early 1990s, the Putnam County Health 
Department and the USEPA conducted limited soil sampling at properties near the northern 
mine entrance to evaluate the potential for exposures for people who may frequent the mine. 
They found high levels of arsenic in surface soils. Concentrations of arsenic up to 32,100 parts 
per million (ppm) were found in surface soils. In May 1988, the Putnam County Health 
Department placed warning signs near the northern mine entrance to alert persons to high 
arsenic levels in soil and tailing piles. 
 
In 2016, arsenic contaminated sediments were found in the holding tanks of the alternate 
drinking water supply installed by the USEPA in the 1980s, which resulted in an additional site 
investigation. In August 2017, a USEPA contractor conducted a soil investigation of four 
properties. In December 2017, samples were collected at six additional properties and one 
previously sampled property, for a total of ten properties sampled between the two events 
[Weston Solutions, Inc. 2017; 2018a]. In June 2018, the USEPA collected additional soil samples 
from all ten properties [Weston Solutions, Inc. 2018b]. In 2017, the New York State Department 
of Environmental Conservation (NYSDEC) independently conducted an investigation in the 
nearby Nimham Mountain MUA near the southern mine shaft and exploratory pits. The NYSDEC 
investigation did not include residential properties but provided sampling data from both areas 
known to be impacted by mining activities as well as background areas. The USEPA provided 
residents with their 2017 and 2018 soil sample results and recommendations on how to reduce 
the potential for exposure to arsenic in soil. 
 
In October 2018, the USEPA collected drinking water samples (before and after water 
treatment systems) and documented that filter systems installed and maintained by residents 
to remove contaminants from their drinking water continue to be effective, with the exception 
of one property. The USEPA recommended that the homeowner follow the manufacturer’s 
suggested maintenance requirements to replace the filter or install a system capable of 
removing contaminants.  
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Based on the more extensive data available on arsenic in soil as compared to 
groundwater/private wells, the fact that the soil concentrations are quite elevated relative to 
common background and health screening levels, and the USEPA’s request for this health 
consultation to focus on residential soils, this report centers on the potential exposures 
occurring from soil. An assessment of drinking water would not be expected to substantially 
alter the findings of elevated health risk contained in this health consultation. 
 
Site Visits 
 
On August 3, 2017, staff from the NYSDOH, NYSDEC, USEPA, and Putnam County Health 
Department visited the site. On November 7, 2018, NYSDOH, ATSDR, and USEPA conducted a 
site visit. 
 
The 2017 site visit consisted of touring the residential property that includes the northern mine 
entrance and the nearby Nimham Mountain MUA where the southern mine entrance is 
located. During the 2017 site visit, staff noted that the area is well-forested with significant 
elevation changes throughout. The northern mine entrance is mostly filled in and the interior of 
the mine itself is not easily accessed. The sign previously placed near the northern mine shaft 
by the Putnam County Health Department was found face down on a fallen tree near the 
entrance to the ravine that contains the shaft entrance. Signage on the property indicates that 
the property owner is aware of the presence of the mine. The former ski slope area constructed 
in the 1950s is overgrown and does not appear to be accessed frequently due to steep terrain. 
Remnants of the former ski lift electrical and lighting system are visible, confirming the location 
of the slope. At the nearby Nimham Mountain MUA, the hiking trails appeared to be well-used 
and were largely bare soil with visible tailings along portions of the trail. The trails are near 
former mine exploratory pits that remain in the area. In May 2018, ‘Danger Restricted Area Do 
Not Enter’ signs were located near the mine entrance and exploratory pits, and ‘Caution’ signs 
notifying the public that arsenic contaminated soils have been detected in the area were 
posted by the NYSDEC along hiking trails and at the mine entrance and exploratory pits. 
 
During the 2018 site visit, staff viewed each of the ten residential properties that are the 
subject of this health consultation, either from the property boundary or from within the 
boundaries, depending on whether the property owner granted access. Seven of the properties 
have homes on them that are occupied either full or part-time. Staff also revisited the Nimham 
Mountain MUA trails adjacent to the residential properties. 
 
During the 2018 site visit, the USEPA staff provided the NYSDOH and ATSDR details of each of 
the ten residential properties and preliminary soil sampling results. NYSDOH staff recorded the 
number of occupants for each property, along with the presence of children, pets, livestock, 
gardens, and play areas. NYSDOH staff also noted the direction of overland flow for 
precipitation runoff, and surface soil sampling results were compared to property features. 
Livestock (e.g., cattle and chickens) were observed at one property. The residents told the 
USEPA staff they eat eggs produced at this property, but no milk or meat products are 
produced. The poultry area had been voluntarily relocated based on soil sampling results and 
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USEPA recommendations. No significant play areas were noted during the site visit, with the 
exception of an outdoor trampoline on one property. Gardening was observed on two 
properties: one vegetable garden in native soil, and one raised bed garden, for which the 
source of the soil is unknown 
 
Demographics 
 
The residential properties of concern are in the Town of Kent, Putnam County, New York, which 
is an area of about 40 square miles. The United States Census Bureau reports a population of 
13,352, of which 76.6% are Caucasian, 5.7% are African-American, about 1.0% Asian, 0.6% 
Native American, and 16.1% Hispanic [United States Census Bureau 2017]. The ten properties in 
this health consultation encompass about 19 acres. Residential homes exist on seven 
properties. Less than 25 people live on the potentially affected properties; residents of one 
household live there only part-time. 
 
Community Health Concerns 
 
The community has raised both health- and property-related concerns. USEPA staff working 
with the community identified the most frequent concerns expressed by residents. One 
resident reports keeping children from playing in areas of exposed soil in the yard. Residents 
report significant concern about the impact of the level of arsenic on property values and 
property assessments for tax purposes. Residents have asked the USEPA about arsenic clean-up 
concentrations. Cancer cases have been reported in the area of concern. In the past, some 
residents in the study area were hospitalized due to arsenic exposure from their drinking water 
wells [NYSDOH 1987]. More recently, an unconfirmed report indicates case of elevated arsenic 
levels in blood. Residents have questioned whether local, state, and federal officials should 
allow people to live in the area, knowing that the arsenic mine exists. In June 2018, one 
household contacted Congressman Sean Patrick Maloney for assistance with the arsenic issue 
[personal communication, Sandra Richards, USEPA, November 2018]. 
DISCUSSION 
 
The health consultation process assesses whether people have been exposed in the past, are 
currently exposed, or potentially could be exposed in the future to hazardous substances and, if 
so, whether that exposure is harmful or potentially harmful, and should therefore be stopped 
or reduced [ATSDR 2005]. The method for assessing whether a health hazard to a community 
exists is to evaluate environmental data (contaminants); determine whether a completed 
exposure pathway exists from a contaminant source to a receptor population (exposure 
evaluation); and, if so, determine whether exposure to the contamination is at a level that 
poses a health concern (public health implications evaluation).  
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Environmental Contamination 
 
USEPA obtained soil data from depths up to 24 inches below the ground surface at ten 
residential properties in 2017 and 2018. Discrete soil samples were obtained from six-inch 
intervals at each sample location. Sample analyses were performed by a USEPA approved 
contract laboratory for total arsenic. Data on arsenic concentrations were obtained using 
approved laboratory analytical methods. All laboratory samples were also analyzed using an X-
ray fluorescence (XRF) screening tool. The XRF is a screening tool and accuracy can vary based 
on the composition of the sample. For this reason, the NYSDOH used only laboratory validated 
soil data to evaluate exposure and risks. For the purpose of estimating exposures, the NYSDOH 
used arsenic concentrations found in the zero to six-inch soil interval, which is considered 
shallow soil. 
 
Sampling information for each property is found in Table 1. For privacy purposes, the properties 
are identified as Properties 1 through 10. 
 
Table 1. Arsenic Mine Residential Properties 
 Shallow Surface Soil Arsenic Results 
Location 
Number of Samples 
Collecteda 
Range  
(mg/kg) 
Property 1 13 19.7 – 49,300 
Property 2 9 10.3 - 6050 
Property 3 8 26.6 – 56,000 
Property 4 5 19.6 – 20,600 
Property 5 7 24.3 - 181 
Property 6 10 3.2 - 687 
Property 7 6 22 - 317 
Property 8 7 9 - 99.5 
Property 9 8 66.5 - 1520 
Property 10 7 3.6 - 841 
a Laboratory validated samples collected from the zero to six-inch interval below ground surface
mg/kg = milligrams of arsenic per kilogram of soil 
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Exposure Pathways 
 
An exposure pathway is the process by which a person can come into contact with a 
hazardous substance that originates from some source of contamination. There are three 
basic exposure routes: inhalation, ingestion, or direct contact with skin. A completed exposure 
pathway occurs when all five of the following elements exist: 
 
1. Source of contamination; 
2. Environmental media and transport mechanism; 
3. Point of exposure; 
4. Route of exposure; and 
5. Receptor population. 
 
A potential exposure pathway exists when any one of the five elements comprising an exposure 
pathway is missing or uncertain. 
Completed Exposure Pathway for Residential Properties 
Residents whose yards are the subject of this health consultation could be exposed to 
arsenic contaminated shallow soil through ingestion and dermal contact. 
Potential Completed Pathway for Vacant Residential Properties 
Persons using the vacant properties (i.e., properties with no habitable buildings) could 
be exposed to arsenic contaminated shallow soil on these properties through ingestion 
and dermal contact. 
The source of contamination is the point at which the contaminant is released to the 
environment (e.g., waste disposal area or point of discharge). If the original source is unknown, 
the contaminant source is the soil, air, biota, or water (environmental media) that are 
contaminated at the point of exposure. The point of exposure is a location where actual or 
potential human contact with a contaminated medium could occur. 
Environmental media and transport mechanisms carry contaminants from the source to points 
where people could be exposed.  
The route of exposure is the way a contaminant enters or contacts the body (i.e., ingestion, 
inhalation, or absorption through the skin).  
The receptor populations are those who are exposed or could be exposed to contaminants at a 
point of exposure.  
Fruits and vegetables grown in arsenic-contaminated soil can take up arsenic [Meharg and 
Hartley-Whitaker 2002; Zhao et al. 2008], and eating these homegrown fruits and vegetables 
can contribute to arsenic exposure. Because the requested focus of this health consultation is 
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the evaluation of health risks from exposure to arsenic in soil through incidental ingestion and 
dermal contact, this evaluation does not address the potential contribution of this food 
exposure pathway, nor the potential for arsenic exposure through consumption of home-raised 
animal products. Consideration of these additional potential exposure pathways may likely 
support and strengthen the conclusions and recommendations provided in this document. 
Exposure to arsenic in soil by the inhalation pathway is not assessed in this health consultation 
because the contribution of this pathway to the total arsenic exposure is negligible (compared 
to ingestion and dermal contact) and would not change the conclusions. 
Public Health Implications 
The maximum arsenic soil concentration at all properties exceeds both the 6 NYCRR Part 375 
New York State Residential Soil Clean Up Objective of 16 mg/kg [NYSDEC/NYSDOH 2006] and 
ATSDR’s chronic Environmental Media Evaluation Guide of 16 mg/kg [ATSDR 2019]. 
Soil Cleanup Objectives are contaminant-specific soil concentrations that represent remedial 
goals, and consider current, intended, or reasonably anticipated future land use. They are set at 
a soil concentration at which health effects are not likely to occur. ATSDR’s chronic 
Environmental Media Evaluation Guides are comparison values used to identify contaminants 
that require further evaluation; they are considered protective of public health.2   
The maximum arsenic soil concentration at all properties also exceeds ATSDR’s short-term 
(acute) Environmental Media Evaluation Guide of 27 mg/kg for a pica child. [ATSDR 2019]. At 
eight properties, the maximum arsenic soil concentration exceeds ATSDR’s short-term 
Environmental Media Evaluation Guide of 260 mg/kg for non-pica children. ATSDR’s acute 
Environmental Media Guides are soil comparison values used to identify contaminants for 
further evaluation. They are considered protective against health effects resulting from short-
term (14 days or less) exposure.  
Because the concentrations exceed both the New York State Soil Clean Up Objective and the 
ATSDR Environmental Media Evaluation Guides, the health risks for exposure to arsenic in soil 
on the residential properties were further evaluated. 
Risk Assessment Methods 
The following sections summarize a risk assessment for arsenic in soil on the residential 
properties. In environmental health, risk assessment is a process that is used to characterize the 
health risks to humans from environmental exposures [USEPA 2018]. It uses a standard 
approach that combines assumptions about the frequency and magnitude of the exposures 
with information about the toxicity of the chemical to draw conclusions about the risk for 
human health effects. Risk assessment is used as a tool to evaluate potential exposures; it 
                                                     
2 Both the New York State Residential Soil Cleanup Objective and the ATSDR chronic Environmental Health 
Evaluation Guide for arsenic are based on background levels because the health based soil value derived from 
arsenic toxicity information and generic assumptions of daily exposure via soil ingestion are below typical arsenic 
background levels in soil.  
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cannot be used to predict actual health outcomes. Information obtained from risk assessments 
is one of several considerations in the development of risk management decisions about 
reducing exposures to environmental chemicals. 
The NYSDOH estimated arsenic exposures using methods from ATSDR’s Exposure Dose 
Guidance for Soil and Sediment Ingestion [ATSDR 2018] and Exposure Dose Guidance for 
Soil/Sediment Dermal Absorption [ATSDR 2016]. The NYSDOH evaluated long-term health risks 
assuming people are exposed to soil and indoor dust (from outdoor soil) by incidental ingestion 
and dermal contact seven days per week for the part of the year when the ground is not frozen 
and/or there is no snow cover.3 Because the length of time people could have been exposed to 
contaminated soil is unknown, the NYSDOH used an exposure duration of 33 years to evaluate 
cancer risks, which is the 95th percentile value for residential occupancy [USEPA 2011]. 
For properties having at least eight surface soil samples for arsenic, the NYSDOH used the 95 
percent upper confidence limit (95% UCL) of the arithmetic mean soil concentration to 
determine the exposure point concentrations for site-related contaminants.4  The exposure 
point concentration is the contaminant concentration in soil that a person could be exposed to, 
and is used to evaluate cancer and non-cancer health risks from exposure to arsenic in soil. The 
95% UCL provides a conservative estimate of the average concentration.  
For properties having fewer than eight sample results, both the maximum detected soil arsenic 
level and the average soil arsenic level from the property were used as the exposure point 
concentrations. To evaluate short-term exposures involving soil ingested in a single episode, the 
NYSDOH used the maximum detected soil arsenic level from each property. A summary of the 
sampling data and the exposure point concentrations used for each property is found in 
Appendix B, Table B1. 
The NYSDOH estimated lifetime cancer risks by multiplying the estimated arsenic exposure by 
the USEPA arsenic cancer potency factor [USEPA 1995]. The cancer potency factor is a 
numerical estimate of a contaminant’s carcinogenic strength (potency). The NYSDOH evaluated 
the non-cancer health effects risk for seven age ranges by comparing the estimated arsenic 
exposures from soil to its USEPA reference dose [USEPA 1991]. A reference dose is a lifetime 
exposure to the contaminant that is expected to be without appreciable risk for non-cancer 
health effects.  
Short-term health risks resulting from a single episode of soil ingestion were evaluated by 
comparing the exposure based on the highest arsenic soil concentration on each property to 
ATSDR’s acute minimal risk level (MRL) for arsenic [ATSDR 2007]. All evaluations of arsenic in 
soil assume a relative bioavailability factor of 60% [USEPA 2016; ATSDR 2018] to account for the 
fraction of arsenic that is released from the soil matrix and absorbed following ingestion. A 
                                                     
3The ground is not frozen and/or there is no snow cover in New York State for an average of 224 days per year. 
4 To determine the exposure point concentrations for properties with at least eight surface soil samples, data were 
analyzed using ProUCL 5.1.00 (USEPA 2016) developed by the USEPA to calculate the 95% UCL. 
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general summary of the health effects of arsenic is presented in Appendix C. Examples of 
calculations for the evaluation of cancer and non-cancer health risks are found in Appendix D. 
Cancer Risks 
Based on convincing evidence from scientific studies of people exposed to high levels of arsenic 
in drinking water, ingestion of arsenic increases the risk for skin, lung and bladder cancer 
[ATSDR 2007; NRC 2001; NTP 2016]. The USEPA and US Department of Health and Human 
Services classify arsenic as a known human carcinogen [USEPA 1991; NTP 2016].  
The estimated increased lifetime cancer risk posed by long-term exposure to arsenic in surface 
soil on the residential properties ranged from 4 in 100,000 to 6 in 100 (Table 2). If the 95% UCL 
and maximum arsenic soil values are used to represent exposure, all ten properties have 
estimated lifetime cancer risk levels that typically trigger measures to reduce exposure (i.e., 1 in 
10,000 or higher). For six properties, the estimated lifetime cancer risk is 1 in 1,000 or higher. 
Estimated cancer risks for several of the properties are unusually high for environmental 
exposures. USEPA’s generally acceptable risk for environmental exposures ranges from 1 in 
10,000 to 1 in 1,000,000 as discussed in the National Contingency Plan (NCP), 40 CFR 300.430. 
The NYSDOH concludes that the arsenic on the residential properties poses a significantly 
elevated risk for cancer health effects. 
The NYSDOH has increased concern about the significance of the estimated cancer risk because 
of evidence from studies of people and animals that suggests the very young could be more 
sensitive to the carcinogenic effects of arsenic than adults [Ahlborn et al. 2009; Marshall et al. 
2007; Smith et al. 2006; Tokar et al, 2011; Waalkes et al. 2003, 2006, 2007, 2009]. 
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Table 2: Estimated Lifetime Cancer Risk for Long-Term Exposure to  
Arsenic in Soil on Residential Properties on the Arsenic Mine Site 
Parcel 
Arsenic Soil 
Concentration (mg/kg)a 
Estimated  
Lifetime Cancer Riskb 
Property 1 48,071c 6 in 100 
Property 2 4,247c 5 in 1,000 
Property 3 25,406c 3 in 100 
Property 4 
20,600d 3 in 100 
4,142e 5 in 1,000 
Property 5 
181d 2 in 10,000 
79e 1 in 10,000 
Property 6 512c 6 in 10,000 
Property 7 
317d 4 in 10,000 
116e 1 in 10,000 
Property 8 
100d 1 in 10,000 
35e 4 in 100,000 
Property 9 1,398c 2 in 1,000 
Property 10 
841d 1 in 1,000 
199e 2 in 10,000 
a For properties having 8 or more surface soil samples, the arsenic exposure point concentration is the 95% 
UCL of the mean.  For properties having less than 8 surface soil samples, both the maximum and average 
arsenic concentrations are used as the exposure point concentration. 
b The cancer risk is calculated by multiplying the estimated arsenic exposure from soil for each of seven age 
groups by the USEPA cancer potency factor for arsenic [USEPA 1995].  The cancer risks for each age group 
are then added to obtain an estimate of the lifetime cancer risk for 33 years of exposure to arsenic in soil 
at each property. Cancer risks estimates at higher exposures have additional uncertainty because the 
assumed shape of the dose-response curve used to derive the cancer potency factor may no longer hold.  
See Appendix D for additional details on the cancer risk calculations. 
c Denotes 95% UCL of the mean arsenic soil concentration. 
d Denotes maximum arsenic soil concentration. 
e Denotes average arsenic soil concentration.  
mg/kg = milligrams of arsenic per kilogram of soil 
 
Non-cancer Risks 
Long-Term Exposure 
The estimated long-term exposure to the arsenic in residential surface soil exceeded the USEPA 
arsenic reference dose of 0.0003 mg/kg/day [USEPA 1991] on all ten properties. The arsenic 
reference dose is based on skin darkening (hyperpigmentation) and localized overgrowth of 
skin (keratosis) in humans exposed to high levels of arsenic in their drinking water over long 
periods of time [USEPA 1991]. Because soil on the properties exceeded the reference dose 
(hazard quotient greater than 1, Table 3), the NYSDOH evaluated the margin of exposure, which 
is a measure of how many times lower the soil arsenic exposure is when compared to the 
arsenic exposure that has been shown to cause non-cancer health effects. The higher the 
margin of exposure, the greater the difference (and margin of protection) between the 
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estimated soil exposure and the human effect level. A margin of exposure equal to 1 means 
that the estimated soil exposure is the same as the human effect level, and a margin of 
exposure less than one means that the estimated exposure in soil is higher than the exposure 
that has caused health effects. Similarly, if the margin of exposure is 10, this means that the 
estimated exposure is 10 times below the human effect level. 
The estimated long-term exposure to arsenic in soil on four properties is greater than the 
arsenic exposure level that caused hyperpigmentation in humans (margin of exposure less than 
1; properties 1, 2, 3 and 4; Table 3). This effect level (0.014 mg/kg/day [USEPA 1991]) is 
exceeded by 27-fold on property 1, 14-fold on property 3, 11-fold on property 4, and 2-fold on 
property 2. Therefore, long-term exposure to arsenic in soil on these properties poses a 
significantly elevated risk for non-cancer health effects, such as hyperpigmentation and 
keratosis. 
On property 9, the soil exposure is about equal to the human effect level (margin of exposure 
of 1.3). For the other properties (properties 5, 6, 7, 8, and 10), the margin of exposure ranges 
from about 2 to 51 (Table 3). For these properties, this means the difference between the 
arsenic exposure from soil and the arsenic effect level in humans is too small, which indicates 
inadequate protection exists against non-cancer health effects. The NYSDOH concludes that 
long-term exposure to soil arsenic at these residential properties constitutes a significantly 
elevated risk for long-term non-cancer health effects.  
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Table 3:  Non-cancer Hazard Quotients for Long-Term Exposure  
to Arsenic in Soil on Residential Properties on the Arsenic Mine Site 
Parcel 
Arsenic Soil 
Concentration 
(mg/kg)a 
Estimated 
Exposure 
(mg/kg/day)b 
Hazard  
Quotientc 
Margin  
of Exposured 
Property 1 48,071e 0.38 1,269 < 1 
Property 2 4,247e 0.034 112 < 1 
Property 3 25,406e 0.20 671 < 1 
Property 4 
20,600f 0.16 544 < 1 
4,142g 0.033 109 < 1 
Property 5 
181f 0.0014 4.7 10 
79g 0.0006 2 22 
Property 6 512e 0.0041 14 3.5 
Property 7 
317f 0.0025 8 6 
116g 0.00091 3 15 
Property 8 
100f 0.00078 2.6 18 
35g 0.00027 0.9 51 
Property 9 1,398e 0.011 37 1.3 
Property 10 
841f 0.0066 22 2.1 
199g 0.0016 5 9 
a For properties having eight or more surface soil samples, the arsenic exposure concentration is the 95% UCL of 
the mean. For properties having less than 8 surface soil samples, both the maximum and average arsenic 
concentrations are used as exposure point concentrations. 
b Exposure estimates are for an infant, for whom the soil ingestion rate and body weight yield the largest 
contaminant dose among the seven life stages evaluated (see Appendix D). Contaminant exposure is assumed 
to occur via soil ingestion and dermal exposure. Examples of detailed calculations are presented in Appendix 
D. Estimated exposures were rounded to two significant figures for presentation in the text tables. 
c The hazard quotient is calculated by dividing the estimated contaminant exposure by the USEPA arsenic 
reference dose of 0.0003 mg/kg/day [USEPA 1991], which the ATSDR has adopted as its chronic MRL. The 
highest hazard quotient, calculated using ATSDR’s reasonable maximum exposure parameters for infants, is 
shown (see also Appendix D). 
d The margin of exposure is calculated by dividing the human effect level for arsenic (0.014 mg/kg/day [USEPA 
1991]) by the estimated arsenic exposure from soil. A margin of exposure less than 1 means the estimated 
exposure is higher than the human arsenic exposure reported to have caused health effects. 
e Denotes 95% UCL of the mean arsenic soil concentration. 
f Denotes maximum arsenic soil concentration. 
g Denotes average arsenic soil concentration. 
mg/kg = milligrams of arsenic per kilogram of soil; mg/kg/day = milligrams of arsenic per kilogram of body 
weight per day  
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Short-Term Exposure 
The NYSDOH also evaluated the health risks associated with a one-time episode in which a 1 to 
2-year-old child is assumed to ingest both an unusually large amount of soil (5 grams, 
representing pica behavior) or the daily amount of soil specified in ATSDR’s reasonable 
maximum exposure scenario (200 milligrams). In each case, the soil concentration is assumed 
to be the highest level of arsenic found in surface soil samples on each property. The arsenic 
exposures in these short-term scenarios (estimated using ATSDR guidance [ATSDR 2018]) are 
compared to the ATSDR acute MRL for arsenic of 0.005 mg/kg/day [ATSDR 2007]. The ATSDR 
acute MRL is a short-term exposure (up to 14 days) that is expected to be without an 
appreciable risk for non-cancer health effects. The acute MRL is based on swelling (edema) of 
the face and gastrointestinal and upper respiratory symptoms in people exposed to arsenic-
contaminated soy sauce for 2-3 weeks [ATSDR 2007].  The specific health effects include 
nausea, vomiting, headaches, stomach cramps, diarrhea, fatigue, chills, sore throat, and nasal 
discharge. These effects typically diminish once the exposure to arsenic is stopped. 
Short-Term Exposure from Pica Behavior 
For all the properties, a single ingestion of a large amount of soil (5 grams) by a 1 to 2-year-old 
child exhibiting pica behavior results in exposures that exceed the ATSDR acute MRL (hazard 
quotient greater than 1, Table 4). Since the MRL is exceeded, the NYSDOH evaluated the short-
term margin of exposure, or how many times lower the short-term arsenic soil exposure is, 
when compared to the short-term arsenic exposure that causes health effects.  This evaluation 
showed that for eight properties (properties 1, 2 ,3, 4, 6, 7, 9, and 10), the estimated short-term 
exposure to arsenic in soil resulting from pica behavior is greater than the short-term arsenic 
exposure level reported to cause edema and gastrointestinal and upper respiratory symptoms 
in humans (margin of exposure less than 1, Table 4). For three properties (properties 1, 3, and 
4), the estimated exposure exceeds this short-term effect level (0.05 mg/kg/day [ATSDR 2007]) 
more than 100-fold. Since pica behavior for a 1 to 2-year-old child can result in an arsenic soil 
exposure that significantly exceeds exposures known to cause short-term arsenic health effects, 
the arsenic levels in soil pose an immediate and significant threat to human health and 
constitute an urgent public health hazard.  For the remaining properties where pica behavior 
resulted in an estimated exposure that exceeded the acute MRL (properties 5 and 8), the 
margin of exposure is too small, which indicates inadequate protection exists against short-
term non-cancer health effects, and arsenic in soil on these properties constitutes a significantly 
elevated risk for the short-term non-cancer arsenic health effects. 
Short-Term Exposure from RME Soil Ingestion 
Using the reasonable maximum exposure (RME) soil ingestion rate (200 milligrams/episode), 
the exposure at seven properties exceeds the MRL (hazard quotient greater than 1, Table 4). 
Since the MRL is exceeded, the NYSDOH again evaluated the short-term margin of exposure for 
these properties. This evaluation showed that the arsenic soil exposure exceeds the short-term 
effect level on properties 1, 2, 3, and 4 (margin of exposure less than 1, Table 4). Because 
incidental ingestion of soil (assuming the RME ingestion rate of 200 milligrams per episode for a 
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1 to 2-year-old child) can result in an arsenic exposure that exceeds exposures known to cause 
short-term arsenic health effects, the arsenic levels in soil on properties 1, 2, 3 and 4 pose an 
immediate and significant threat to human health and constitute an urgent public health 
hazard.  
For properties 6, 9, and 10, the short-term arsenic exposure from soil in the RME scenario 
exceeds ATSDR’s acute MRL and results in a margin of exposure that is too small, which 
indicates inadequate protection exists against short-term non-cancer health effects. Therefore, 
exposure to arsenic in soil on these residential properties shown in Table 4 constitutes a 
significantly elevated risk for the short-term non-cancer arsenic health effects previously 
described. 
Table 4: Non-cancer Hazard Quotients for Short-Term Exposure  
to Arsenic in Soil on Residential Properties on the Arsenic Mine Site 
Parcel 
Arsenic 
Soil 
Conc.a 
(mg/kg) 
Estimated 
Pica Behavior 
Exposureb 
(mg/kg/day) 
Estimated 
RME 
Exposureb 
(mg/kg/day) 
Short-
Term 
HQc 
 
Pica 
Short-
Term 
HQc  
 
RME 
Short-
Term 
MOEd 
 
Pica 
Short-
Term 
MOEd 
 
RME 
Property 1 49,300 13 0.52 2,595 104 < 1 < 1 
Property 2 6,050 1.6 0.064 318 13 < 1 < 1 
Property 3 56,000 15 0.59 2,947 118 < 1 < 1 
Property 4 20,600 5.4 0.22 1,084 43 < 1 < 1 
Property 5 181 0.048 0.0019 9.5 0.38 1.0 26 
Property 6 687 0.18 0.0072 36 1.4 < 1 6.9 
Property 7 317 0.083 0.0033 17 0.7 < 1 15 
Property 8 100 0.026 0.0011 5.2 0.2 1.9 47 
Property 9 1,520 0.4 0.016 80 3.2 < 1 3.1 
Property 10 841 0.22 0.0089 44 1.7 < 1 5.7 
a The highest arsenic concentration in soil on each property is used as the exposure point concentration to 
evaluate short-term exposure risks. 
b Exposure estimates are for 1 to 2-year-old child weighing 11.4 kilograms who ingests 5,000 milligrams (pica) or 
200 milligrams (RME) of soil per episode (see Appendix D). Estimated exposures were rounded to two significant 
figures for presentation in the text tables. 
c The hazard quotient is calculated by dividing the estimated contaminant exposure by the ATSDR acute arsenic 
MRL of 0.005 mg/kg/day [ATSDR 2007]. 
d The margin of exposure is calculated by dividing the short-term human effect level for arsenic (0.05 mg/kg/day 
[ATSDR 2007]) by the estimated arsenic exposure from soil. A margin of exposure less than 1 means the 
estimated exposure is higher than the short-term human arsenic exposure reported to have caused health 
effects. 
HQ = hazard quotient; mg/kg = milligrams of arsenic per kilogram of soil; mg/kg/day = milligrams of arsenic per 
kilogram of body weight per day; MOE = margin of exposure; RME = reasonable maximum exposure 
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STRENGTHS AND LIMITATIONS 
This evaluation of the risks for adverse health effects from arsenic in residential shallow soil has 
both strengths and limitations. The strengths include consideration of sensitive subgroups, use 
of high-end estimates for soil ingestion rates, consideration of both the oral and dermal 
pathways for arsenic exposure from soil, and use of the maximum arsenic soil level or the 95% 
UCL of the mean arsenic soil level as exposure point concentrations. 
The focus of this health consultation is the evaluation of health risks from exposure to arsenic in 
soil on the residential properties. The limitations include uncertainties about how well the soil 
sampling data represent people’s actual exposure. The evaluation does not consider potential 
additional arsenic exposures through past or potential current inhalation of arsenic 
contaminated soil or dust, consumption of untreated drinking water, consumption of home 
raised animal products, or consumption of fruits and vegetables grown in contaminated soil. 
This evaluation also does not consider other potential arsenic exposures that could result from 
residents’ use of nearby trails in the Nimham Mountain MUA. Though action is planned by 
NYSDEC to cover the trails with gravel in early 2019, until that time soil from these trails could 
be tracked into homes on footwear or by pets, leading to additional exposure by incidental 
ingestion and dermal contact. Consideration of these additional potential exposure pathways 
would not change the conclusions and recommendations provided in this document but may 
likely support and strengthen them.  
The conclusions described in this report are based on an evaluation of USEPA’s soil data 
obtained in 2017 and 2018 from the zero to six inches below ground surface interval. The 
NYSDOH typically evaluates risks for adverse health effects from exposures to contaminants in 
surface soils collected from zero to two inches below a grass cover system because this interval 
is considered a better indicator of actual exposure than the zero to six-inch interval. The 
difference in sampling depth of the available data introduces a small level of uncertainty in the 
estimates of contaminant exposure. 
CONCLUSIONS 
The evaluation of arsenic contaminated soil at select residential properties on the Arsenic Mine 
Site is the primary focus of this health consultation and the basis for the conclusions and 
recommendations. 
CONCLUSION 1 
The NYSDOH and ATSDR conclude that short-term ingestion exposure of children to arsenic in 
shallow (zero to six inches) soils with the highest arsenic levels at residential properties on the 
Arsenic Mine Site pose an immediate and significant threat to human health, thus constituting 
an urgent public health hazard.  
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BASIS FOR CONCLUSION 
Short-term exposure to arsenic in residential soil could result in adverse health effects. For all 
ten residential properties evaluated, a single ingestion of a large amount of soil (i.e., 5 grams) 
containing the maximum arsenic soil level found at each property, by a 1 to 2-year-old child 
exhibiting pica behavior, results in an arsenic dose that either exceeds or approaches the short-
term arsenic exposure level that causes non-cancer health effects. On seven properties, a single 
ingestion of a smaller amount of soil (i.e., 200 milligrams) containing the maximum arsenic level 
results in an arsenic dose that either exceeds or approaches the short-term arsenic exposure 
level that causes non-cancer health effects. The health effects that can result from short-term, 
high-level exposure to arsenic include vomiting, headaches, stomach cramps, diarrhea, and 
facial swelling, especially around the eyes.  These effects are typically temporary and should 
subside when exposure to arsenic ceases. 
CONCLUSION 2 
The NYSDOH and ATSDR conclude that long-term ingestion and dermal exposure of children 
and adults to arsenic in shallow soil at residential properties on the Arsenic Mine Site pose a 
significant threat to human health and constitute a public health hazard. 
BASIS FOR CONCLUSION 
Long-term exposure to arsenic in residential soil could result in adverse health effects. For all 
ten residential properties evaluated, long-term arsenic exposure in soil results in an estimated 
lifetime cancer risk of over 1 in 10,000. For six of the residential properties, the arsenic 
exposure results in an estimated lifetime cancer risk of 1 in 1,000 or higher, and for three 
properties, the estimated cancer risk is over 1 in 100, which is unusually high for environmental 
exposures. Long term exposure to high levels of arsenic is known to cause cancer of the skin, 
lung, and bladder in humans. Regarding non-cancer health risks, long-term exposure to arsenic 
in soil at all properties results in an arsenic dose that either exceeds or approaches the long-
term arsenic exposure level that causes health effects. Long-term human exposure to arsenic 
also causes skin hyperpigmentation and keratosis, or a darkening and thickening of the skin on 
the hands and feet, as well as other adverse health effects [USEPA 1991; ATSDR 2007]. 
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RECOMMENDATIONS 
 
1. Based on the significantly increased risk for adverse health effects, the NYSDOH and 
ATSDR strongly recommend that the USEPA implement immediate actions to prevent 
or reduce the potential for residents, especially children, to be exposed to arsenic in 
the contaminated residential soils. 
 
2. Until a long-term remedial action can be put in place, the NYSDOH and ATSDR 
recommend residents implement the following interim measures to reduce arsenic 
exposure: 
 
 People, especially children, should minimize direct and repeated contact with 
bare soils.  
 Maintain a grass or mulch cover wherever possible to help prevent direct 
contact with the soil. 
 Wipe shoes on doormat or remove shoes before entering the home. Apply 
general good housekeeping practices by periodically damp mopping floors, 
vacuuming (using a HEPA filter if available), and cleaning furniture to help 
reduce exposure to outdoor soil that might be tracked indoors. Avoid the use 
of brooms. 
 Avoid unnecessary digging in the dirt. 
 Children and adults should wash hands after outdoor activities to help 
reduce the potential for exposure. 
 Wash children’s toys regularly. 
 Refrain from landscaping activities that increase exposure to soil and create 
bare areas of soil.  
 Refrain from eating food or smoking when working in the yard. 
 Refrain from eating home raised fruits, vegetables, and animal products. If 
residents choose to garden, they should grow crops in soils in raised bed 
gardens and containers with clean soil imported from a non-contaminated 
area or bagged soil bought commercially instead of the existing soil. 
Residents should wear gloves when gardening and dispose or wash gloves 
thoroughly after each use.  
 Regularly wash pets that may go outdoors and contact the soil. 
 Properly maintain water treatment systems in accordance with the 
manufacturer’s specification. 
 
3. People should contact the NYSDOH if they have additional questions regarding how 
to reduce exposure. The NYSDOH and ATSDR also recommend that residents who are 
concerned about possible exposure to, and effects from, arsenic contaminated soil 
should discuss these concerns with their health care provider. 
  
 22 
 
PUBLIC HEALTH ACTION PLAN 
 
1. The NYSDOH will coordinate with the ATSDR, NYSDEC, Putnam County Health Department, 
USEPA, and the Town of Kent to quickly provide health education to residents whose 
properties are affected by arsenic contamination. Activities may include public meetings, 
public availability sessions, preparation of factsheets, and information sessions and mailings 
for local physicians to assist them in addressing their patients’ concerns. 
 
2. The NYSDOH and ATSDR will continue to coordinate with the USEPA, NYSDEC, and Putnam 
County Health Department to implement the recommendations contained in this health 
consultation. 
 
3. The NYSDOH and ATSDR will review information as it becomes available, evaluate the public 
health implications of any additional sampling results, and recommend public health 
actions, as needed. 
 
4. The NYSDOH will continue, as needed, to provide support to community members related 
to this health consultation or other site-related health concerns that may arise. This report 
will be placed in the local repository and provided to people who request it. 
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Figure A1. Location of the Site 
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Table B1. Arsenic Mine Residential Properties Surface Soil Arsenic Results 
Location 
Number of 
Samples 
Range  
(mg/kg) 
aMean   
(mg/kg) 
 95% UCLb
(mg/kg) 
Property 1 13 19.7 – 49,300 10,690 48,071 
Property 2 9 10.3 – 6,050 873 4,247 
Property 3 8 26.6 – 56,000 12,734 25,406 
Property 4 5 19.6 – 20,600 4,142 na 
Property 5 7 24.3 - 181 79 na 
Property 6 10 3.2 - 687 193 512 
Property 7 6 22 - 317 116 na 
Property 8 7 9 - 99.5 35 na 
Property 9 8 66.5 – 1,520 298 1,398 
Property 10 7 3.6 - 841 199 na 
a The mean arsenic result is used as the exposure point concentration for properties on which less than 8 validated samples 
were taken. 
b The 95% upper confidence limit (UCL) of the mean is used as the exposure point concentration for properties on which 8 or 
more validated samples were taken. 
   mg/kg = milligrams of arsenic per kilogram of soil; na = not applicable. 
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Appendix C: Health Effects of Site-Related Chemicals 
 
All chemicals can cause health effects. The risk for adverse health effects from any chemical 
depends on the chemical’s toxicity, the amount of the chemical to which a person is exposed, 
and how long and how often the exposure occurs. The risks also depend on the characteristics 
of the exposed person, such as age, sex, diet, family traits, lifestyle, genetic background, the 
presence of other chemicals in their body (e.g., alcohol, prescription drugs), and general state 
of health. 
 
Arsenic is found in ores of copper, lead and other minerals, and in soil, groundwater and 
surface water. Arsenic compounds have been used in wood preservatives and in commercial 
pesticides. Below is some general information about the kinds of health effects that are 
associated with exposure to the arsenic. 
 
Exposure to arsenic is known to cause cancer in humans. There is convincing evidence from a 
large number of scientific studies of people who have been exposed to high levels of arsenic in 
drinking water that ingestion of inorganic arsenic increases the risk for skin, lung and bladder 
cancer [ATSDR 2007; NRC 2001; NTP 2016]. The USEPA and US Department of Health and 
Human Services classify arsenic as a known human carcinogen [USEPA 1991; NTP 2016].  Some 
people exposed to high levels of arsenic in drinking water for long periods of time also 
developed a characteristic darkening and thickening of the skin on the hands and feet. Long-
term exposure to high levels of arsenic is also associated with nerve and liver damage, high 
blood pressure, damage to the vascular system (i.e., blood vessels of the heart and brain), and 
could lead to learning deficiencies [ATSDR 2007]. 
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Appendix D: Sample Calculations 
 
 
Table D1. ATSDR Recommended Soil/Indoor Dust or Sediment Ingestion Rates 
Exposure Group 
Soil/Indoor Dust or 
Sediment Ingestion1 
(mg/kg/day) 
Body Weight2 (kg) 
Birth to < 1 year 150 7.8 
1 to < 2 years 200 11.4 
2 to < 6 years 200 17.4 
6 to < 11 years 200 31.8 
11 to < 16 years 100 56.8 
16 to < 21 years 100 71.6 
Adults ≥ 21 years 100 80 
Children with pica behavior 
(1 to < 2 and 2 to < 6 years) 
5,000 per event 11.4 
1Soil/indoor dust or sediment ingestion rates are the reasonable maximum exposure scenario from  
ATSDR’s Exposure Dose Guidance for Soil/Sediment Ingestion [ATSDR 2018]. 
2Mean body weight 
mg/kg/day = milligrams per kilogram per day; kg = kilograms 
 
Sample calculations use the 95% UCL of the mean to evaluate chronic arsenic exposure and the 
maximum arsenic soil concentration to evaluate acute exposure. All calculations are done using 
ATSDR’s Exposure Dose Guidance for Soil/Sediment Ingestion [ATSDR 2018] and ATSDR’s 
Exposure Dose Guidance for Soil/Sediment Dermal Absorption [ATSDR 2016].  
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1. Calculation of Chronic Non-cancer Dermal Administered Dose: 
 
𝐶soil 𝑥 𝐸𝐹 𝑥 𝐶𝐹 𝑥 𝐴𝐹 𝑥 𝐴𝐵𝑆d  𝑥 𝑆𝐴
𝐷𝐴𝐷 =    
𝐵𝑊 𝑥 𝐴𝐵𝑆𝐺𝐼
 
DAD = Dermal administered dose (mg/kg/day)   ABSd = Dermal absorption fraction  
Csoil = Contaminant concentration in soil (mg/kg)                SA = Surface area available for contact (cm2) 
EF = Exposure frequency      BW = Age-specific body weight (kg) 
CF = Conversion factor (10-6 kg/mg)     ABSGI = Gastrointestinal absorption factor 
AF = Adherence factor of soil to skin (mg/cm2/event)    
 
Calculation of Arsenic Dermal Doses for Property 1 
Exposure Point Concentration1 = 48,071 mg/kg 
Sample Depth: 0-6 inches 
Age Group 
Soil 
Concentration 
(mg/kg) 
Exposure 
2Frequency  
Soil Adherence 
3Factor  
2(mg/cm -
event) 
Dermal 
Absorption 
4Factor  
Surface 
5 Area
(cm2) 
Body 
Weight 
(kg) 
Dermal 
Absorbed 
6Dose  
(mg/kg/day) 
GI 
Absorption 
7Factor  
Dermal 
Administered 
8Dose  
(mg/kg/day) 
Birth to < 1 yr 48,071 0.614 0.2 0.03 1,772 7.8 4.02E-02 1 4.02E-02 
Child 1 to < 2 yr 48,071 0.614 0.2 0.03 2,299 11.4 3.57E-02 1 3.57E-02 
Child 2 to < 6 yr 48,071 0.614 0.2 0.03 2,592 17.4 2.64E-02 1 2.64E-02 
Child 6 to < 11 yr 48,071 0.614 0.2 0.03 3,824 31.8 2.13E-02 1 2.13E-02 
Child 11 to <16 yr 48,071 0.614 0.2 0.03 5,454 56.8 1.70E-02 1 1.70E-02 
Child 16 to <21 yr 48,071 0.614 0.2 0.03 6,083 71.6 1.50E-02 1 1.50E-02 
Adults ≥ 21 yr 48,071 0.614 0.07 0.03 6,030 80 4.67E-03 1 4.67E-03 
1Exposure point concentration = 95% upper confidence limit of the mean (mg/kg) 
2Exposure frequency = (224 days/365 days) x (7 days/7 days). Based on exposure 7 days per week over 224 days per year with no snow cover or frozen ground in New York State. 
3The soil adherence factor (AF) is a measure of soil adherence to the skin [USEPA 2004] 
4The dermal absorption factor (ABSd) represents the fraction of a chemical that is absorbed through the skin after dermal contact 
5Surface area (SA) is the amount of skin surface that is available for contact with soil [USEPA 2011] 
6 Dermal absorbed dose = (soil concentration) *(EF)*(CF)*(AF)*(ABSd)*(SA)/ (Body weight) 
7The GI absorption factor (ABSGI) is the fraction of chemical absorbed by the gastrointestinal tract [EPA 2004] 
8Dermal administered dose = (dermal absorbed dose)/(ABSGI) 
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2. Calculation of Chronic Non-cancer Ingestion Exposure Dose: Total Non-cancer Dose from Ingestion and Dermal Exposure, 
Hazard Quotient, and Margin of Exposure: 
 
 
A. Non-cancer Ingestion Exposure Dose: 
 
𝐶 ×  𝐼𝑅 ×  𝐶𝐹 ×  𝐸𝐹 ×  𝑅𝐵𝐴
D =  
𝐵𝑊
 
D = Oral dose (mg/kg/day) 
C = Contaminant concentration in soil (mg/kg)  
IR = Age-specific soil intake rate (mg/day) 
CF = Conversion factor (10-6 kg/mg)    
EF = Exposure frequency  
BW = Age-specific body weight (kg)    
RBA = relative bioavailability for arsenic (0.6) 
 
 
 
B. Total Non-cancer Dose from Ingestion and Dermal Exposure: 
Total oral and dermal exposure dose = dermal administered dose + ingestion exposure dose  
 
 
C. Hazard Quotient (HQ): 
𝑇𝑜𝑡𝑎𝑙 𝑜𝑟𝑎𝑙 𝑎𝑛𝑑 𝑑𝑒𝑟𝑚𝑎𝑙 𝑎𝑑𝑚𝑖𝑛𝑖𝑠𝑡𝑒𝑟𝑒𝑑 𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒 𝑑𝑜𝑠𝑒 
HQ =   
𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑑𝑜𝑠𝑒
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Calculation of Arsenic Ingestion and Dermal Non-cancer Risk in Soil for Property 1 
Exposure Point Concentration1 = 48,071 mg/kg 
Sample Depth: 0-6 inches 
 
 
 
 
Age Group 
Soil 
Concentration 
(mg/kg) 
Soil 
Intake2 
(mg/day) 
Exposure 
Frequency3 
Body 
Weight 
(kg) 
Relative 
Bioavailability 
Factor4 
Ingestion 
Exposure 
Dose5 
(mg/kg/day) 
Dermal 
Administered 
Dose6 
(mg/kg/day) 
Total Oral 
and Dermal 
Exposure 
Dose7 
(mg/kg/day) 
Reference 
Dose8 
(mg/kg/day) 
Hazard Quotient9 
Birth to < 1 yr 48,071 150 0.614 7.8 0.60 3.40E-01 4.02E-02 3.81E-01 0.0003 1,268.69 
Child 1 to < 2 yr 48,071 200 0.614 11.4 0.60 3.11E-01 3.57E-02 3.46E-01 0.0003 1,154.11 
Child 2 to < 6 yr 48,071 200 0.614 17.4 0.60 2.03E-01 2.64E-02 2.30E-01 0.0003 766.07 
Child 6 to < 11 yr 48,071 200 0.614 31.8 0.60 1.11E-01 2.13E-02 1.33E-01 0.0003 442.03 
Child 11 to <16 yr 48,071 100 0.614 56.8 0.60 3.12E-02 1.70E-02 4.82E-02 0.0003 160.53 
Child 16 to <21 yr 48,071 100 0.614 71.6 0.60 2.47E-02 1.50E-02 3.98E-02 0.0003 132.53 
Adults ≥ 21 yr 48,071 100 0.614 80 0.60 2.21E-02 4.67E-03 2.68E-02 0.0003 89.31 
1Exposure point concentration = 95% upper confidence limit of the mean (mg/kg) 
2ATSDR-recommended soil ingestion rates [ATSDR 2018] 
3Exposure frequency = (224 days/365 days) x (7 days/7 days). Based on exposure 7 days per week over 224 days per year with no snow cover or frozen ground in New York State. 
4The ratio of the absolute bioavailability (absorbed dose) of arsenic in soil to the absolute bioavailability of arsenic in water [ATSDR 2016]. 
5Exposure dose = (soil concentration)*(soil intake)*(exposure frequency)*(CF)*(RBA)/(body weight). 
6Dermal administered dose is calculated in the previous table  
7Total oral and dermal exposure dose = ingestion exposure dose + dermal administered dose 
8Reference dose = 0.0003 mg/kg/day [USEPA 1991]. 
9Hazard quotient = total contaminant dose/reference dose. 
mg/kg: milligrams per kilogram; mg/kg/day: milligrams per kilogram per day; RME: reasonable maximum exposure; CTE: central tendency exposure. 
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D. Margin of Exposure (MOE):  
 
 
MOE =
𝐸𝑓𝑓𝑒𝑐𝑡 𝐿𝑒𝑣𝑒𝑙 𝑜𝑟 𝐿𝑂𝐸𝐿
𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒𝑑 𝑂𝑟𝑎𝑙 𝑎𝑛𝑑 𝐷𝑒𝑟𝑚𝑎𝑙 𝐸𝑥𝑝𝑜𝑠𝑢𝑟𝑒 𝐷𝑜𝑠𝑒
 
 
Effect level: For chronic arsenic exposure, lowest observed effect level (LOEL) for hyperpigmentation, keratosis, and vascular 
complication in humans of 0.014 mg/kg/day [USEPA 1991]. 
  
 
 
Age Group 
Total Oral and Dermal Exposure 
Dose (mg/kg/day) 
Margin of Exposure1 
Birth to < 1 yr 3.81E-01 0.04 
Child 1 to < 2 yr 3.46E-01 0.04 
Child 2 to < 6 yr 2.30E-01 0.06 
Child 6 to < 11 yr 1.33E-01 0.11 
Child 11 to <16 yr 4.82E-02 0.29 
Child 16 to <21 yr 3.98E-02 0.35 
Adults ≥ 21 yr 2.68E-02 0.52 
1The ratio of the exposure associated with health effects (a LOEL of 0.014 mg/kg/day [USEPA 1991]) 
 and the combined oral and dermal exposure from soil. A margin of exposure less than one means 
 that the oral and dermal exposure exceeds the exposure associated with health effects. 
mg/kg/day = milligrams per kilogram per day 
 
 
 
 
 3. Calculation of Cancer Dermal Administered Dose: 
 
𝐶soilt 𝑥 𝐸𝐷/𝐴𝑇 𝑥 𝐶𝐹 𝑥 𝐸𝐹 𝑥  𝐴𝐹 𝑥 𝐴𝐵𝑆d  𝑥 𝑆𝐴
𝐷𝐴𝐷 =    
𝐵𝑊 𝑥 𝐴𝐵𝑆𝐺𝐼
 
DAD = Dermal administered dose (mg/kg/day)   AF = Adherence factor of soil to skin (mg/cm2/event)   
Csoil = Contaminant concentration in soil (mg/kg)   ABSd = Dermal absorption fraction   
ED = Exposure duration (years)     SA = Surface area available for contact (cm2)   
AT= Averaging time (78 years)     BW = Age-specific body weight (kg) 
CF = Conversion factor (10-6 kg/mg)    ABSGI = Gastrointestinal absorption factor 
EF = Exposure frequency      
Calculation of Arsenic Dermal Doses for Property 1 
Exposure Point Concentration = 48,071 mg/kg 
Sample Depth: 0-6 inches 
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Soil 
Age Group 
Exposure 
Duration 
(years) 
Fraction 
of 
Lifetime 
Soil 
Concentration 
(mg/kg) 
Exposure 
2Frequency  
Adherence 
3Factor  
2(mg/cm -
event) 
Dermal 
Absorption 
4Factor  
Surface 
5 Area
(cm2) 
Body 
Weight 
(kg) 
Dermal 
Absorbed 
6Dose  
(mg/kg/day) 
GI 
Absorption 
7Factor  
Dermal 
Administered 
8Dose  
(mg/kg/day) 
Birth to < 1 yr 1 0.0128 48,071 0.614 0.2 0.03 1,772 7.2 5.16E-04 1 5.16E-04 
Child 1 to < 2 yr 1 0.0128 48,071 0.614 0.2 0.03 2,299 11.4 4.58E-04 1 4.58E-04 
Child 2 to < 6 yr 4 0.0513 48,071 0.614 0.2 0.03 2,592 17.4 1.35E-03 1 1.35E-03 
Child 6 to < 11 yr 5 0.0641 48,071 0.614 0.2 0.03 3,824 31.8 1.36E-03 1 1.36E-03 
Child 11 to <16 yr 5 0.0641 48,071 0.614 0.2 0.03 5,454 56.8 1.09E-03 1 1.09E-03 
Child 16 to <21 yr 5 0.0641 48,071 0.614 0.2 0.03 6,083 71.6 9.64E-04 1 9.64E-04 
Adults ≥ 21 yr 12 0.1538 48,071 0.614 0.07 0.03 6,030 80 7.18E-04 1 7.18E-04 
1Exposure point concentration = 95% upper confidence limit of the mean (mg/kg) 
2Exposure frequency = (224 days/365 days) x (7 days/7 days). Based on exposure 7 days per week over 224 days per year with no snow cover or frozen ground in New York State. 
3The soil adherence factor (AF) is a measure of soil adherence to the skin [USEPA 2004]. 
4The dermal absorption factor (ABSd) represents the fraction of a chemical that is absorbed through the skin after dermal contact. 
5Surface area (SA) is the amount of skin surface that is available for contact with soil [USEPA 2011]. 
6Dermal absorbed dose = (soil concentration)*(ED/AT)*(CF)*(EF)*(AF)*(ABSd)*(SA)/ (Body weight). 
7The GI absorption factor (ABSGI) is the fraction of chemical absorbed by the gastrointestinal tract [USEPA 2004]. 
8Dermal administered dose  = (dermal absorbed dose)/(ABSGI). 
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4. Calculation of Cancer Ingestion Exposure Dose; Total Cancer Dose from Ingestion and Dermal Exposure, and Cancer Risk:  
 
A. Cancer Ingestion Exposure Dose 
 
𝐸𝐷
𝐶 × ( ) ×  𝐼𝑅 × 𝐶𝐹 ×  𝐸𝐹 ×  𝑅𝐵𝐴 𝐴𝑇D =  
𝐵𝑊
 
D = Oral dose (mg/kg/day) 
C = Contaminant concentration in soil (mg/kg)  
ED = Exposure duration (years) 
AT = Averaging time (78 years) 
IR = Age-specific soil intake rate (mg/day)  
CF = Conversion factor (10-6 kg/mg) 
EF = Exposure frequency  
BW = Age-specific body weight (kg) 
RBA = relative bioavailability of arsenic (0.6) 
 
 
B. Total Cancer Dose from Ingestion and Dermal Exposure and Cancer Risk: 
 
  Total oral and dermal cancer dose = cancer dermal administered dose + cancer ingestion dose  
 
C. Cancer Risk 
 
Cancer risk = Total oral and dermal administered exposure dose x cancer potency factor 
 
D. Lifetime cancer risk  
Lifetime cancer risk = sum of cancer risk for each age group 
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1Exposure point concentration = 95% upper confidence limit of the mean (mg/kg) 
2Exposure frequency = (224 days/365 days) x (7 days/7 days). Based on exposure 7 days per week over 224 days per year with no snow cover or frozen ground in New York State. 
3ATSDR-recommended soil ingestion rates [ATSDR 2018].  
4The ratio of the absolute bioavailability (absorbed dose) of arsenic in soil to the absolute bioavailability of arsenic in water [ATSDR 2016]. 
5Exposure dose = (fraction of lifetime)*(soil concentration)*(conversion factor)*(exposure frequency)*(soil intake)/(body weight). 
6Dermal administered dose is calculated in the previous table  
7Total oral and dermal exposure dose = ingestion exposure dose + dermal administered dose 
8Cancer risk = (total exposure dose)*(cancer potency factor) 
Cancer potency factor = (1.5 mg/kg/day)-1 [USEPA 1995]. 
mg/kg: milligrams per kilogram; mg/kg/day: milligrams per kilogram per day;  
 
 
 
 
 
 Calculation of Arsenic Ingestion and Dermal Cancer Risk in Soil for Property 1 
Exposure Point Concentration1 = 48,071 mg/kg, Exposure Duration = 33 years 
Sample Depth: 0-6 inches 
 
 
 
  
Age Group 
Exposure 
Duration 
(years) 
Fraction 
of 
Lifetime 
Soil 
Concentration 
(mg/kg) 
Exposure 
Frequency
2 
Body 
weight 
(kg) 
Soil 
3Intake  
(mg/day) 
Relative 
Bioavailability 
4Factor  
Ingestion 
Exposure 
5Dose  
(mg/kg/day) 
Dermal 
Administere
6 d Dose
(mg/kg/day) 
Total Oral 
and Dermal 
Exposure 
7 Dose
(mg/kg/day) 
Cancer Risk8 
Birth to < 1 yr 1 0.013 48,071 0.614 7.8 150 0.6 4.36E-03 5.16E-04 4.88E-03 7.31E-03 
Child 1 to < 2 yr 1 0.013 48,071 0.614 11.4 200 0.6 3.9E-03 4.58E-04 4.4E-03 6.6E-03 
Child 2 to < 6 yr 4 0.051 48,071 0.614 17.4 200 0.6 1.0E-02 1.35E-03 1.2E-02 1.8E-02 
Child 6 to < 11 yr 5 0.064 48,071 0.614 31.8 200 0.6 7.1E-03 1.36E-03 8.5E-03 1.3E-02 
Child 11 to <16 yr 5 0.064 48,071 0.614 56.8 100 0.6 2.0E-03 1.09E-03 3.1E-03 4.6E-03 
Child 16 to <21 yr 5 0.064 48,071 0.614 71.6 100 0.6 1.5E-03 9.64E-04 2.5E-03 3.8E-03 
Adults ≥ 21 yr 12 0.154 48,071 0.614 80 100 0.6 3.4E-03 7.18E-04 4.1E-03 6.2E-03 
Total risk for 33 
                                             exposure 
year 
5.9E-02 
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5. Calculation of Acute Non-cancer Exposure Dose and Margin of Exposure: 
A. Acute Non-cancer Ingestion Exposure Dose for a Child 1 year to < 2 years: 
D =
𝐶 ×  𝐼𝑅 × 𝐶𝐹 × 𝐸𝐹 ×  𝑅𝐵𝐴
𝐵𝑊
 
 
D = Oral dose (mg/kg/day) 
C = Contaminant concentration in soil (mg/kg)  
IR = Age-specific soil intake rate for a pica child (5,000 mg/day)  
CF = Conversion factor (10-6 kg/mg) 
EF = Exposure frequency 
BW = Age-specific body weight (11.4 kg)    
RBA = relative bioavailability factor for arsenic (0.6) 
 
Calculation of Acute Arsenic Ingestion Non-cancer Risk in Soil for Property 1   
Exposure Point Concentration1 = 49300 mg/kg   
Sample Depth: 0-6 inches   
Age Group 
Soil 
Concentration 
(mg/kg) 
Soil Intake2 
(mg/day) 
Exposure 
Frequency3 
Body 
Weight 
(kg) 
Relative 
Bioavailability 
Factor4 
Exposure Dose5 
(mg/kg/day) 
Acute MRL6 
(mg/kg/day) 
Hazard Quotient7 
RME Pica RME Pica RME Pica 
Child 1 to < 2 yr 49,300 200 5,000 1.000 11.4 0.60 5.19E-01 1.30E+01 0.005 104 2,595 
1Exposure point concentration = maximum soil arsenic concentration at the property (mg/kg) 
2ATSDR-recommended soil ingestion rates [ATSDR 2018] 
3Exposure frequency = 1 for the acute scenario  
4The ratio of the absolute bioavailability (absorbed dose) of arsenic in soil to the absolute bioavailability of arsenic in water [ATSDR 2016]. 
5Exposure dose = (soil concentration)*(soil intake)*(conversion factor)*(exposure frequency)*(relative bioavailability)/(body weight). 
6Acute MRL = 0.005 mg/kg/day [ATSDR 2007]. 
7Hazard quotient = contaminant dose/MRL. 
mg/kg: milligrams per kilogram; mg/kg/day: milligrams per kilogram per day; RME: reasonable maximum exposure 
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B.  Calculation of Margin of Exposure for Acute Exposure for a Child 1 year to < 2 years 
 
MOE =
𝐸𝑓𝑓𝑒𝑐𝑡 𝐿𝑒𝑣𝑒𝑙 𝑜𝑟 𝐿𝑂𝐸𝐿
𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒𝑑 𝐴𝑐𝑢𝑡𝑒 𝐸𝑥𝑝𝑜𝑠𝑢𝑟𝑒 𝐷𝑜𝑠𝑒
 
 
Effect level: For acute arsenic exposure, lowest observed effect level (LOEL) for edema and gastrointestinal effects in people of 0.05 
mg/kg/day [ATSDR 2007]. 
 
 
Age Group 
Exposure Dose (mg/kg/day) 
 
Margin of Exposure1 
 
RME Pica RME Pica 
Child 1 to < 2 yr 5.19E-01 1.30E+01 0.10 0.004 
1The ratio of the exposure associated with short-term health effects (a LOEL of 0.05 mg/kg/day [ATSDR 2007]) and 
the short-term oral dose from soil.  A margin of exposure less than one means that the oral exposure exceeds the 
exposure associated with health effects. 
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